STOPFLU: Is it Possible to Reduce the Number of Days Off in Office Work by Improved Hand-hygiene?
NCT00821509 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 683
Last updated 2012-03-08
Summary
Improved hand hygiene is known to reduce transmission of both respiratory (RTI) and gastrointestinal infections (GTI) under "semi-closed" conditions such as hospitals, day-care centres and schools. It is not known if similar interventions would have the desired effect in a regular office work. This study is aiming to investigate this possibility by recruiting volunteers from several companies in the Helsinki Region. The two intervention groups will receive detailed instructions e.g. for proper coughing and sneezing, and for regular cleaning of hands with either standard liquid soap or with alcohol-based gel rubbing. Third group will serve as the control and is advised not to change their previous behaviour in this respect. The participants will report weekly possible RTI or GTI symptoms and related days off through internet. The study is planned to run about 18 months to cover the seasonal variation of the epidemics of the causative different viruses.
Conditions
- Respiratory Infection
- Gastroenteritis
Interventions
- BEHAVIORAL
-
Hand washing
Instructions for proper coughing and sneezing, and for reduced hand shaking, frequent hand washing in office and at home
- BEHAVIORAL
-
Disinfectant rubbing
Instructions for proper coughing and sneezing, and for reduced hand shaking; frequent rubbing of hands with alcohol containing disinfectant in office and at home
Sponsors & Collaborators
-
Finnish Work Environment Fund
collaborator OTHER -
Finnish Institute of Occupational Health
collaborator OTHER -
Berner Oy
collaborator INDUSTRY -
Farmos Oy
collaborator INDUSTRY -
Kesko Oyj
collaborator UNKNOWN -
Nordea Bank Finland Plc
collaborator UNKNOWN -
Outokumpu
collaborator UNKNOWN -
Outokumpu Technogy Oyj
collaborator UNKNOWN -
Suomen Osuuskauppojen Keskuskunta (SOK)
collaborator UNKNOWN -
S-Pankki
collaborator OTHER -
Finnish Institute for Health and Welfare
lead OTHER_GOV
Principal Investigators
-
Tapani Hovi, MD PhD · National Public Health Institute, Finland
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2010-07-31
- Completion
- 2011-12-31
Countries
- Finland
Study Locations
More Related Trials
-
Evaluation of Efficacy and Safety of Oral Solution Resfenol in Reducing Symptoms of Common Cold And Flu
NCT01158326 ·Status: COMPLETED ·Phase: PHASE3
-
Statin Therapy in Acute Influenza
NCT02056340 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses
NCT00762476 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Assessment of an Anti-Cold Preparation in the Symptomatic Treatment of Common Cold and Flu-Like Syndrome
NCT00940836 ·Status: UNKNOWN ·Phase: PHASE3
-
The Protective Effect of Mask Wearing Against Respiratory Tract Infections
NCT05690516 ·Status: COMPLETED ·Phase: NA
-
Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method
NCT01986361 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Time of Pain Relief of Fast Acting Aspirin Versus Acetaminophen in Subjects Diagnosed With Sore Throat Pain
NCT01453400 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza
NCT00957996 ·Status: COMPLETED ·Phase: PHASE3
-
Antiviral Therapy for Influenza A H1N1
NCT00985582 ·Status: COMPLETED
-
Norketotifen for the Treatment of Uncomplicated Influenza-like Illness
NCT04043923 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial of KT07 Capsule in the U.S.A
NCT02867358 ·Status: COMPLETED ·Phase: PHASE2
-
Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough
NCT02822287 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of a Mouth and Throat Rinse for the Treatment of Acute Sore Throat
NCT06244615 ·Status: COMPLETED ·Phase: NA
-
Alleviation of Common Cold Symptoms
NCT06106880 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects
NCT04729764 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes
NCT01053377 ·Status: UNKNOWN ·Phase: PHASE4
-
STIP: Statin Trial for Influenza Patients
NCT00970606 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness
NCT04610047 ·Status: COMPLETED ·Phase: PHASE2
-
Fluoxetine to Reduce Intubation and Death After COVID19 Infection
NCT04377308 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Zinc Acetate Lozenges on the Rate of Recovery From the Common Cold
NCT03309995 ·Status: COMPLETED ·Phase: NA
-
Rapid Flu Tests in Travelers With Fever
NCT00821626 ·Status: COMPLETED ·Phase: NA
-
Effect of Early Antiviral Therapy on Duration of Cough in Flu Patients
NCT03618407 ·Status: UNKNOWN
-
A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers
NCT04405466 ·Status: COMPLETED
-
Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral Suspension
NCT06643156 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal
NCT04694612 ·Status: UNKNOWN ·Phase: PHASE3